Sunday, August 22, 2021 12:56:56 PM
How can one forecast the buy out price based on the fact that we have 3.75B shares outstanding and with all the patents? Is there an industry standard formula to estimate? What will be a fair value?
If a company was to buy out normally is it that share holders are paid cash for the current shares? Or do some take overs simply dissolve current shares and allocate new shares of the company doing the buy out based on the buy out price?
Example will RGBP shares become null and void say if Moderna bought us out and allocate us Moderna shares?
Cheers!
If a company was to buy out normally is it that share holders are paid cash for the current shares? Or do some take overs simply dissolve current shares and allocate new shares of the company doing the buy out based on the buy out price?
Example will RGBP shares become null and void say if Moderna bought us out and allocate us Moderna shares?
Cheers!
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM

